The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of 3 participants upon introduction of Risperdal, with the third responding in similar fashion upon final dose adjustment. Each participant reported no occurrences of side effects. These findings suggest that Risperdal was well tolerated, and may serve as a safe and effective treatment modality for this challenging population.
| Identifer | oai:union.ndltd.org:pacific.edu/oai:scholarlycommons.pacific.edu:uop_etds-3693 |
| Date | 01 January 2001 |
| Creators | Patterson, Brian Robert |
| Publisher | Scholarly Commons |
| Source Sets | University of the Pacific |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | University of the Pacific Theses and Dissertations |
Page generated in 0.0016 seconds